Michael Dockal

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach.

Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach.

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 15, 2024

Concizumab improves clot formation in hemophilia A under flow.

Concizumab improves clot formation in hemophilia A under flow.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 02, 2023

Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.

Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 10, 2022

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.

Journal: Haematologica

Published: October 26, 2021

Heterogeneity in Bleeding Tendency and Arthropathy Development in Individuals with Hemophilia.

Heterogeneity in Bleeding Tendency and Arthropathy Development in Individuals with Hemophilia.

Journal: Seminars in thrombosis and hemostasis

Published: February 26, 2021

A bispecific antibody demonstrates limited measurability in routine coagulation assays.

A bispecific antibody demonstrates limited measurability in routine coagulation assays.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: May 30, 2020

Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys.

Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys.

Journal: The Journal of pharmacology and experimental therapeutics

Published: May 21, 2019

In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents.

In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 03, 2017

Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.

Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: May 01, 2015

Role of exosite binding modulators in the inhibition of Fxa by TFPI.

Role of exosite binding modulators in the inhibition of Fxa by TFPI.

Journal: Thrombosis and haemostasis

Published: April 29, 2015

Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells.

Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells.

Journal: BMC biotechnology

Published: March 06, 2015

Screening of complex fucoidans from four brown algae species as procoagulant agents.

Screening of complex fucoidans from four brown algae species as procoagulant agents.

Journal: Carbohydrate polymers

Published: June 26, 2014

Showing 1-12 of 22

Last Updated: 09/26/2026